Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M4,544Revenue $M71.9Net Margin (%)-113.8Z-Score12.9
Enterprise Value $M4,155EPS $-0.8Operating Margin %-97.3F-Score0
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-119.2Higher ROA y-yN
Price/Book10.610-y EBITDA Growth Rate %0Quick Ratio3.1Cash flow > EarningsN
Price/Sales59.75-y EBITDA Growth Rate %0Current Ratio3.7Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-15.5Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-21.5Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M101ROI % (ttm)-110.7Gross Margin Increase y-yN

Gurus Latest Trades with XON

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
XONT Boone Pickens 2014-12-31 Buy 0.53%$16.61 - $28.02
($23.05)
$ 43.2847%New holding10,000
XONDavid Einhorn 2014-12-31 Sold Out -0.05%$16.61 - $28.02
($22.97)
$ 43.2847%Sold Out0
XONDavid Einhorn 2014-09-30 Reduce-0.06%$17.86 - $26.59
($21.29)
$ 43.2851%Reduce -47.39%197,278
XONDavid Einhorn 2014-06-30 Reduce-0.39%$15.3 - $25.93
($21.15)
$ 43.2851%Reduce -72.81%375,000
XONJean-Marie Eveillard 2014-06-30 Buy 0.04%$15.3 - $25.93
($21.15)
$ 43.2851%New holding661,564
XONDavid Einhorn 2014-03-31 Reduce-0.26%$22.5 - $36.82
($28.82)
$ 43.2833%Reduce -37.58%1,379,014
XONDaniel Loeb 2014-03-31 Add0.18%$22.5 - $36.82
($28.82)
$ 43.2833%Add 18.15%3,000,000
XONT Boone Pickens 2013-12-31 Sold Out -0.47%$17.65 - $25.5
($21.05)
$ 43.2851%Sold Out0
XONDaniel Loeb 2013-12-31 Add0.15%$17.65 - $25.5
($21.05)
$ 43.2851%Add 18.07%2,539,200
XONDaniel Loeb 2013-09-30 Buy 1.2%$21.36 - $29.7
($24.16)
$ 43.2844%New holding2,150,592
XONDavid Einhorn 2013-09-30 Buy 0.86%$21.36 - $29.7
($24.16)
$ 43.2844%New holding2,176,868
XONT Boone Pickens 2013-09-30 Buy 0.47%$21.36 - $29.7
($24.16)
$ 43.2844%New holding12,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

XON is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


XON: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KIRK RANDAL JCEO, 10% Owner 2015-01-27Buy555,556$2745.81view
Reed Thomas D.Chief Science Officer 2014-05-13Buy640$15.6152.37view
Lehr Donald P.Chief Legal Officer 2014-05-13Buy1,850$15.99146.22view
KIRK RANDAL JCEO, 10% Owner 2014-05-13Buy65,173$15.19159.18view
Krishnan Krish SCOO 2014-05-09Buy20,900$14.21177.06view
KIRK RANDAL JCEO, 10% Owner 2014-05-09Buy67,333$15.16159.7view
Krishnan SumaSVP--Product Development 2014-05-09Buy20,900$14.21177.06view
Huang KellySVP-Consumer Sector 2014-05-09Buy3,200$15.78149.49view
Kasser Thomas R.SVP--Food Sector 2014-05-09Buy10,000$13.39194.03view
KIRK RANDAL JCEO, 10% Owner 2014-03-27Buy243,001$25.7253.07view

Press Releases about XON :

    Quarterly/Annual Reports about XON:

    News about XON:

    Articles On GuruFocus.com
    Bill Miller Identifies What Could Be The Stock of The Decade Feb 10 2015 
    5-Year Lows: American Eagle Outfitters, Intrexon Corp, Mack-Cali Realty Corp, and Weight Watchers In Apr 21 2014 
    Daniel Loeb Comments on Intrexon Corporation Jan 22 2014 
    Daniel Loeb Lags S&P But Top New Stocks Advance Jan 07 2014 
    David Einhorn’s New Stocks – TPX, XON, NVR Nov 14 2013 
    Weekly CEO Buys Highlight: XON, ARCP, FSFR, CNTY, RHP Aug 19 2013 

    More From Other Websites
    Air Methods Now a Strong Buy: Is It in Your Portfolio? - Analyst Blog Mar 27 2015
    Soligenix Announces Recent Accomplishments and Year-End 2014 Financial Results Mar 24 2015
    Intrexon (XON): Strong Industry, Solid Earnings Estimate Revisions - Tale of the Tape Mar 24 2015
    Soligenix Announces Recent Accomplishments and Year-End 2014 Financial Results Mar 24 2015
    Cramer Remix: I'm taking a cue from Ariana Grande Mar 23 2015
    Synthetic Biologics Announces Positive Pharmacokinetics Data from Phase 1a and 1b Trials of SYN-004... Mar 19 2015
    Synthetic Biologics Announces Positive Pharmacokinetics Data from Phase 1a and 1b Trials of SYN-004... Mar 19 2015
    Fibrocell Science Appoints Keith A. Goldan, Senior Vice President and Chief Financial Officer Mar 18 2015
    Synthetic Biologics Reports Year End 2014 Financial Results and Operational Highlights Mar 16 2015
    Synthetic Biologics Reports Year End 2014 Financial Results and Operational Highlights Mar 16 2015
    Fibrocell Science Reports Fourth Quarter and Full Year 2014 Financial and Operating Results Mar 13 2015
    Soligenix Announces Publication of Successful Preclinical Efficacy and Immunogenicity Results for... Mar 11 2015
    Soligenix to Present at the 27th Annual ROTH Conference Mar 11 2015
    Increased Earnings Estimates Seen for Intrexon (XON): Can It Move Higher? - Tale of the Tape Mar 11 2015
    Synthetic Biologics' SYN-004 Data for Protection of Microbiome Selected for Late-Breaking Poster... Mar 11 2015
    Synthetic Biologics' SYN-004 Data for Protection of Microbiome Selected for Late-Breaking Poster... Mar 11 2015
    AmpliPhi Announces $13 Million Financing Mar 10 2015
    AmpliPhi BioSciences Corporation Announces $13 Million Financing Mar 10 2015
    Synthetic Biologics to Present at the 27th Annual ROTH Conference Mar 09 2015
    Synthetic Biologics to Report Year End 2014 Financial Results Mar 09 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK